Sarcosine (N-Methylglycine), an endogenous amino acid, is a competitive glycine transporter type I (GlyT1) inhibitor and N-methyl-D-aspartate (NMDA) receptor co-agonist. Sarcosine increases the glycine concentration, resulting in an indirect potentiation of the NMDA receptor. Sarcosine is commonly used for the research of schizophrenia.
性状
Solid
IC50 & Target[1][2]
Human Endogenous Metabolite
体内研究(In Vivo)
Sarcosine (400-800mg/kg; i.p.) significantly raises the threshold for electroconvulsions.Medlife has not independently confirmed the accuracy of these methods. They are for reference only.Animal Model:Albino Swiss mice weighing (25-30 g)
运输条件
Room temperature or refrigerated transport.
储存方式
Powder; -20°C; 3 years; 4°C; 2 years;
ClinicalTrial
结构分类
Amino acids
溶解度数据
体外研究:H2O : ≥ 100 mg/mL(1122.46 mM)DMSO : < 1 mg/mL (ultrasonic) (insoluble or slightly soluble)*≥ means soluble, but saturation unknown.